References
- Copper R L, Goldenberg R L, Creasy R K, DuBard M B, Davis R O, Entman S S, Iams J D, Cliver S P. A multicenter study of preterm birth weight and gestational age-specific neonatal mortality. Am J Obstet Gynecol 1993; 168: 78–84
- Berkowitz G S, Papiernik E. Epidemiology of preterm birth. Epidemiol Rev 1993; 15: 414–443
- McLean M, Walters W A, Smith R. Prediction and early diagnosis of preterm labor: a critical review. Obstet Gynecol Surv 1993; 48: 209–225
- Berghella V, Hayes E, Visintine J, Baxter J. Fetal fibronectin testing for reducing the risk of preterm birth. (Protocol). Cochrane Database Syst Rev 2007; CD006843
- Smith V, Devane D, Begley C M, Clarke M, Higgins S. A systematic review and quality assessment of systematic reviews of fetal fibronectin and transvaginal length for predicting preterm birth. Eur J Obstet Gynecol Reprod Biol 2007; 133: 134–142
- Giles W, Bisits A, Knox M, Madsen G, Smith R. The effect of fetal fibronectin testing on admissions to a tertiary maternal-fetal medicine unit and cost savings. Am J Obstet Gynecol 2000; 182: 439–442
- Joffe G M, Jacques D, Bemis-Heys R, Burton R, Skram B, Shelburne P. Impact of the fetal fibronectin assay on admissions for preterm labor. Am J Obstet Gynecol 1999; 180: 581–586
- Shimoya K, Hashimoto K, Shimizu T, Saji F, Murata Y. Effect of sexual intercourse on fetal fibronectin concentration in cervicovaginal secretions. Am J Obstet Gynecol 1998; 179: 255–256
- Ballard J L, Novak K K, Driver M. A simplified score for assessment of fetal maturation of newly born infants. J Pediatr 1979; 95: 769–774
- Paredes I, Hidalgo L, Chedraui P, Palma J, Eugenio J. Factors associated with inadequate prenatal care in Ecuadorian women. Int J Gynaecol Obstet 2005; 88: 168–172
- Available at: www.jbg.org.ec. (accessed 20 July 2008)
- Chedraui P A, Hidalgo L A, San Miguel G. Cost analysis in a high risk pregnancy Unit. Int J Gynaecol Obstet 2003; 83: 53
- Lockwood C J, Senyei A E, Dische M R, Casal D, Shah K D, Thung S N, Jones L, Deligdisch L, Garite T J. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991; 325: 669–674
- Iams J D, Casal D, McGregor J A, Goodwin T M, Kreaden U S, Lowensohn R, Lockitch G. Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol 1995; 173: 141–145
- Peaceman A M, Andrews W W, Thorp J M, Cliver S P, Lukes A, Iams J D, Coultrip L, Eriksen N, Holbrook R H, Elliott J, et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial. Am J Obstet Gynecol 1997; 177: 13–18
- Goldenberg R L, Mercer B M, Meis P J, Copper R L, Das A, McNellis D. The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. NICHD Maternal Fetal Medicine Units Network. Obstet Gynecol 1996; 87: 643–648
- Tekesin I, Marek S, Hellmeyer L, Reitz D, Schmidt S. Assessment of rapid fetal fibronectin in predicting preterm delivery. Obstet Gynecol 2005; 105: 280–284
- Garcia Alonso L A, Jimenez S G, Ayala Mendez J A, Izquierdo Puente J C, Barahona B E. Clinical usefulness of fetal fibronectin (fFN) expression in cervico-vaginal secretions (CVS). Ginecol Obstet Mex 2002; 70: 379–384
- Garcia Alonso L A, Ayala Mendez J A, Jimenez Solis G, Aguilar Gutierrez F, Diaz Cueto L. Economical impact of preterm delivery management based on fetal fibronectin results. Ginecol Obstet Mex 2004; 72: 385–393
- Peláez L M, Fox N S, Chasen S T. Negative fetal fibronectin: who is still treating for threatened preterm labor and does it help?. J Perinat Med 2008; 36: 202–205